Skip to main content
. Author manuscript; available in PMC: 2018 Mar 29.
Published in final edited form as: Prev Med. 2017 Sep 28;106:38–44. doi: 10.1016/j.ypmed.2017.09.022

Table 2.

Expected reduction in patients with invasive colorectal cancer by 15%, per-person potential life-years (LYs) saved and aggregate potential LYs saved in the population.

Incidence rate in 2007 (per 100,000 population)a,g Incidence rate in 2020 (per 100,000 population)b Projected population in 2020c Expected reduction in the number of CRCd Life expectancy for CRC patients (SE) Life expectancy for reference population (SE) Per-person LYs saved (SE)e Aggregate LYs savedf
Total 46.90 39.90 333,895,553 23,821 149,493
Sex
 Male 54.50 46.33 164,811,926 13,473 10.45 (0.01) 16.73 (0.01) 6.28 (0.01) 84,569
 Female 40.80 34.68 169,083,627 10,348 11.13 (0.01) 17.40 (0.01) 6.27 (0.01) 64,924
Race/ethnicity*
 Non-Hispanic White 46.40 39.44 199,312,742 13,872 10.36 (0.01) 16.41 (0.01) 6.06 (0.01) 84,002
 Non-Hispanic Black 56.10 47.69 41,775,711 3515 10.55 (0.02) 18.31 (0.03) 7.75 (0.02) 27,260
 Hispanic 40.70 34.60 63,784,157 3894 13.34 (0.02) 21.91 (0.03) 8.57 (0.03) 33,380
Age group (years)*
 50–54 57.00 48.45 20,466,535 1750 19.44 (0.03) 28.75 (0.03) 9.31 (0.02) 16,292
 55–59 76.70 65.20 21,747,043 2502 16.06 (0.03) 24.45 (0.02) 8.39 (0.02) 20,989
 60–64 107.40 91.29 21,016,992 3386 12.92 (0.02) 20.45 (0.03) 7.53 (0.02) 25,482
 65–69 162.50 138.13 18,052,082 4400 10.93 (0.02) 16.68 (0.03) 5.75 (0.02) 25,307
 70–74 211.90 180.12 14,744,309 4686 8.51 (0.02) 13.17 (0.02) 4.67 (0.02) 21,864
 75–79 264.50 224.83 10,009,961 3971 6.49 (0.01) 10.16 (0.02) 3.67 (0.02) 14,580
 80+ 333.30 283.31 13,162,518 6581 3.94 (0.01) 6.30 (0.01) 2.36 (0.01) 15,528

SE, standard error.

b

Incidence rate in 2007 × (1–0.15).

c

Source: United States Census Bureau (USCB), 2012. National Population Projections.

d

Expected reduction in the number of CRC patients = Difference in incidence rates between 2007 and 2020 × projected 2020 population.

e

LYs saved = life expectancy of the reference population – life expectancy of CRC patients.

f

Aggregate LYs saved was calculated by multiplying the estimated reduction in the number of CRC patients with per-person LYs saved.

g

Incidence rate for each age group is not age adjusted.

*

p < 0.05 for statistical tests comparing per-person LYs saved between groups.